1-3 of 3
Manuela Zucknick, PhD
Close
Sort by
Journal Articles

Differential DNA Methylation Predicts Response To Combined Treatment Regimens With a DNA Methyltransferase Inhibitor In Acute Myeloid Leukemia (AML)

Maximilian Schmutz, Manuela Zucknick, PhD, Richard F. Schlenk, MD, Konstanze Döhner, MD, Hartmut Döhner, MD, Christoph Plass, PhD, Lars Bullinger, MD, PhD, Rainer Claus, MD
Journal: Blood
Blood (2013) 122 (21): 2539.
https://doi.org/10.1182/blood.V122.21.2539.2539
Published: 2013
Journal Articles

The Relative Significance of ZAP -70 Promoter Methylation As a Prognostic Factor in Previously Untreated Chronic Lymphocytic Leukemia: Validation of Results Using a Second Large CLL Research Consortium (CRC) Patient Data Set

Rainer Claus, MD, Amy S. Ruppert, MAS, David M. Lucas, PhD, Manuela Zucknick, PhD, Laura Z. Rassenti, Ph.D., Andrew Greaves, Donna S. Neuberg, ScD, William G. Wierda, MD, Ph.D., Michael J. Keating, MD, Jennifer R. Brown, MD, PhD, John G Gribben, Kanti R. Rai, M.D., Michael R. Grever, MD, Neil E. Kay, MD, Thomas J. Kipps, MD, PhD, Christoph Plass, PhD, John C. Byrd, MD
Journal: Blood
Blood (2012) 120 (21): 3865.
https://doi.org/10.1182/blood.V120.21.3865.3865
Published: 2012
Journal Articles

Decitabine (DAC) Treatment Induces Very Early In Vivo DNA Methylation and Transcriptome Changes in Primary AML Peripheral Blood Blasts

Rainer Claus, Dietmar Pfeifer, PhD, Maika Almstedt, Björn Hackanson, Manuela Zucknick, PhD, Christoph Plass, Michael Lübbert
Journal: Blood
Blood (2011) 118 (21): 1360.
https://doi.org/10.1182/blood.V118.21.1360.1360
Published: 2011